mutation_id	virus	genotype	gene	aa_change	Ganciclovir	Aciclovir	Cidofovir	Foscarnet	Brincidofovir	Letermovir	Brivudine	Penciclovir	Tomeglovir	Maribavir	Cyclopropavir	Amenamevir	Pritelivir	ref_title	ref_link	ref_doi	strain_generation	test_method	co_gene	co_aa	created_date	created_by	note	control_strain	status
1234	VZV	HJO	ORF36	L73I		1.3	0.7	2.7			1	0.9						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1235	VZV	HJO	ORF36	A163*		5.7	0.9	0.2			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1236	VZV	HJO	ORF36	W225R		5.7	2.1	1.5			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1237	VZV	HJO	ORF36	T256M		5.7	0.3	0.8			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1238	VZV	HJO	ORF36	Q303*		5.7	0.4	0.9			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA	Pol	A955T	01/12/2020	OJCharles			A
1239	VZV	HJO	ORF36	N334*		5.7	0.8	0.6			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1240	VZV	HJO	ORF36	del7-74		5.7	1.3	0.7			133	10						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1241	VZV	HJO	ORF28	T237K		1.1	3.4	2.9			133	1.1						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1242	VZV	HJO	ORF28	A955T		0.9	0.6	0.8			133	0.8						Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate	https://aac.asm.org/content/aac/59/5/2726.full.pdf	doi.org/10.1128/AAC.05115-14	Recombinant BAC 	PRA			01/12/2020	OJCharles			A
1243	VZV	Clinical isolate	ORF36	L332P		5.8												Clinical and Virologic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from 11 Patients with Acquired Immunodeficiency Syndrome	https://academic.oup.com/cid/article/33/12/2061/365806	doi.org/10.1086/324503	Isolated strain 	PRA			01/12/2020	OJCharles		Cha/Oka	A
1244	VZV	Clinical isolate	ORF36	R183*		12												Clinical and Virologic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from 11 Patients with Acquired Immunodeficiency Syndrome	https://academic.oup.com/cid/article/33/12/2061/365806	doi.org/10.1086/324503	Isolated strain 	PRA			01/12/2020	OJCharles		Cha/Oka	A
1245	VZV	Clinical isolate	ORF36	E192*		14		1			36	12						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1246	VZV	Clinical isolate	ORF36	T86A		12		1			38	15						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1247	VZV	Clinical isolate	ORF36	G24R		15		1			40	13						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1248	VZV	Clinical isolate	ORF28	K662E		4		8			2	4						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1249	VZV	Clinical isolate	ORF28	V666L		9		8			1	8						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1250	VZV	Clinical isolate	ORF28	L767S		12		5			1	10						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1251	VZV	Clinical isolate	ORF28	D668Y		4		1			1	2						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1252	VZV	Clinical isolate	ORF28	D668Y		10		4			1	1.4						In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302250/	doi.org/10.1128/JVI.06620-11	Isolated strain 	PRA	pol	M808V	12/01/2020	OJCharles		Oka	A
1253	VZV	Clinical isolate	ORF36	G24E		36												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1254	VZV	Clinical isolate	ORF36	C231*		17.5												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1255	VZV	Clinical isolate	ORF36	E308Q		1.2												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1256	VZV	Clinical isolate	ORF36	I38*		37												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1257	VZV	Clinical isolate	ORF36	V194*		19												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1258	VZV	Clinical isolate	ORF36	L298*		20												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1259	VZV	Clinical isolate	ORF36	R54*		21.3	 											Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1260	VZV	Clinical isolate	ORF36	V171*		23.8												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1261	VZV	Clinical isolate	ORF36	V333*		11.3												Phenotypic and Genotypic Characterization of Acyclovir-Resistant Varicella-Zoster Viruses Isolated from Persons with AIDS	https://academic.oup.com/jid/article/170/1/68/863472	doi.org/10.1093/infdis/170.1.68	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1262	VZV	Clinical isolate	ORF36	C138R		16						15						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA	TK	S242F	12/01/2020	OJCharles		Oka	A
1263	VZV	Clinical isolate	ORF36	R143G		16						15						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1264	VZV	Clinical isolate	ORF36	D129N		8.7						15						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1265	VZV	Clinical isolate	ORF36	K25R		16						15						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1266	VZV	Clinical isolate	ORF36	R143K		16						1.5						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1267	VZV	Clinical isolate	ORF36	E59G		10						11						Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC237457/	doi.org/10.1128/jvi.67.2.1024-1033.1993	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1268	VZV	Clinical isolate	ORF36	E48G		26	4.8	42			1.2	61						Phenotypic and Genetic Characterization of Thymidine Kinase from Clinical Strains of Varicella-Zoster Virus Resistant to Acyclovir	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89493/	doi.org/10.1128/aac.43.10.2412	Isolated strain 	TK functional kinetic assay			12/01/2020	OJCharles		Oka	A
1269	VZV	Clinical isolate	ORF36	R130Q		5												Mutant Varicella-Zoster Virus Thymidine Kinase: Correlation of Clinical Resistance and Enzyme Impairment	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC250677	doi.org/10.1128/jvi.65.12.6407-6413.1991	Isolated strain 	TK functional kinetic assay			12/01/2020	OJCharles		Oka	A
1270	VZV	Clinical isolate	ORF36	L154P		38												Molecular Analysis of the Pyrimidine Deoxyribonucleoside Kinase Gene of Wild-type and Acyclovir-resistant Strains of Varicella-Zoster Virus	https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-69-10-2585#tab2	doi.org/10.1099/0022-1317-69-10-2585	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1271	VZV	Clinical isolate	ORF36	T256A		19	1.2	1				6.7						ACYCLOVIR-RESISTANT CHRONIC VERRUCOUS VACCINE STRAIN VARICELLA IN A PATIENT WITH NEUROBLASTOMA	https://journals.lww.com/pidj/Fulltext/2008/10000/ACYCLOVIR_RESISTANT_CHRONIC_VERRUCOUS_VACCINE.24.aspx	doi.org/10.1097/INF.0b013e318175d85c	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1272	VZV	Clinical isolate	ORF36	S51L		1.5					2	0.7						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1273	VZV	Clinical isolate	ORF36	N119D		2					1.2	0.92						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1274	VZV	Clinical isolate	ORF36	V194A		1					1.2	0.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1275	VZV	Clinical isolate	ORF28	T39A		1					1.2	1.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1276	VZV	Clinical isolate	ORF28	M201I		1					0.8	1.1						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1277	VZV	Clinical isolate	ORF28	M201I		1.5					1.2	1.8						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA	 		12/01/2020	OJCharles		Oka	A
1278	VZV	Clinical isolate	ORF28	G218D		1.6					1	1.9						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1279	VZV	Clinical isolate	ORF28	S386A		2					1	0.9						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1280	VZV	Clinical isolate	ORF28	S386A		2.6					1.2	1.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1281	VZV	Clinical isolate	ORF28	Q402P		1.1					1.2	1.9						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1282	VZV	Clinical isolate	ORF28	T417I		2					1.2	2.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1283	VZV	Clinical isolate	ORF28	G723R		1.1					1.2	1.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1284	VZV	Clinical isolate	ORF28	R753K		1.1					1.2	1.5						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1285	VZV	Clinical isolate	ORF28	V777I		0.7					1.2	1.4						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1286	VZV	Clinical isolate	ORF28	R950C		1.2					1.2	1.3						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1287	VZV	Clinical isolate	ORF28	T1066S		1.9					0.8	2						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1288	VZV	Clinical isolate	ORF28	R1076C		1.1					1.5	1.6						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1289	VZV	Clinical isolate	ORF28	C1185Y		2.9					1.8	2						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1290	VZV	Clinical isolate	ORF28	G186C		Polymorphism	Polymorphism	Polymorphism			Polymorphism	Polymorphism						Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1291	VZV	Clinical isolate	ORF28	S863G		Polymorphism	Polymorphism	Polymorphism			Polymorphism	Polymorphism						Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1292	VZV	Clinical isolate	ORF28	C1159R		Polymorphism	Polymorphism	Polymorphism			Polymorphism	Polymorphism						Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1293	VZV	Clinical isolate	ORF28	I3L		0.9												Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1294	VZV	Clinical isolate	ORF28	V638I		0.6												Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1295	VZV	Clinical isolate	ORF36	R143G		14												Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			12/01/2020	OJCharles		Oka	A
1380	VZV	Clinical isolate	ORF36	S179N		1		1.4			0.7	1						Phenotypic and Genetic Characterization of Thymidine Kinase from Clinical Strains of Varicella-Zoster Virus Resistant to Acyclovir	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89493/	doi.org/10.1128/aac.43.10.2412	Isolated strain 	TK functional kinetic assay			04/02/2021	OJCharles		Oka	A
1647	VZV	Clinical isolate	ORF36	Q90*		Resistant												Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella-Zoster Virus, in an Immunosuppressed Child	https://academic.oup.com/jid/article/188/7/954/820206	doi.org/10.1086/378502	Isolated strain 	TK functional kinetic assay			28/05/2021	OJCharles	Resistant Phenotype not established this was effect on TK activity (which is hand in hand) but not directly a resistance measurement	Oka	A
1648	VZV	Clinical isolate	ORF36	L92P		Resistant												Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction	https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-72-3-623#tab2	doi.org/10.1099/0022-1317-72-3-623		TK functional kinetic assay			28/05/2021	OJCharles		9883	A
1649	VZV	Clinical isolate	ORF36	L92P		Resistant												Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction	https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-72-3-623#tab2	doi.org/10.1099/0022-1317-72-3-623		TK functional kinetic assay			28/05/2021	OJCharles		9883	A
1651	VZV	Oka	ORF36	A29T		1												Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals	https://www.sciencedirect.com/science/article/pii/S0166093416300787	doi.org/10.1016/j.jviromet.2016.03.006	Isolated strain 	PRA			18/11/2021	OJCharles		Oka	A
1652	VZV	Clinical isolate	ORF36	S288L		Polymorphism												Resistance testing of clinical varicella-zoster virus strains	https://www.sciencedirect.com/science/article/pii/S0166354211002841	doi.org/10.1016/j.antiviral.2011.04.005	Isolated strain 	PRA			18/11/2021	OJCharles		Oka	A
1653	VZV	Clinical isolate	ORF36	K186R		1		1			1	1						Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades	https://www.sciencedirect.com/science/article/pii/S1386653217302433#tbl0005	doi.org/10.1016/j.jcv.2017.08.011	Isolated strain 	PRA			18/11/2021	OJCharles	Co-occurs with D545Y , needs to be tested indep	Oka	O
1654	VZV	Clinical isolate	ORF36	A319V		Polymorphism												Molecular Analysis of the Pyrimidine Deoxyribonucleoside Kinase Gene of Wild-type and Acyclovir-resistant Strains of Varicella-Zoster Virus	https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-69-10-2585#tab2	doi.org/10.1099/0022-1317-69-10-2585	Isolated strain 	PRA			18/11/2021	OJCharles		Oka	A
2029	VZV	Clinical isolate	ORF28	Q298K				1										Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype	https://onlinelibrary.wiley.com/doi/abs/10.1002/%28SICI%291096-9071%28199909%2959%3A1%3C84%3A%3AAID-JMV14%3E3.0.CO%3B2-N	doi.org/10.1002/(SICI)1096-9071(199909)59:1<84::AID-JMV14>3.0.CO;2-N	Isolated strain	Cytopathic effect			14/08/2025	OJCharles	Challenging to assign any pol mutation to a phenotype as clearly tk is dominating resistance for example see vrABD	OKA	A
2030	VZV	Clinical isolate	ORF28	S863G				1										Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype	https://onlinelibrary.wiley.com/doi/abs/10.1002/%28SICI%291096-9071%28199909%2959%3A1%3C84%3A%3AAID-JMV14%3E3.0.CO%3B2-N	doi.org/10.1002/(SICI)1096-9071(199909)59:1<84::AID-JMV14>3.0.CO;2-N	Isolated strain	Cytopathic effect			14/08/2025	OJCharles		OKA	A
2031	VZV	Clinical isolate	ORF28	L1095M				1										Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype	https://onlinelibrary.wiley.com/doi/abs/10.1002/%28SICI%291096-9071%28199909%2959%3A1%3C84%3A%3AAID-JMV14%3E3.0.CO%3B2-N	doi.org/10.1002/(SICI)1096-9071(199909)59:1<84::AID-JMV14>3.0.CO;2-N	Isolated strain	Cytopathic effect			14/08/2025	OJCharles		OKA	A
2057	VZV	Clinical isolate	ORF36	Q303*		6		1.8										Acyclovir-resistant Varicella-Zoster virus: Phenotypic and genetic characterization	https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1096-9071(199807)55:3%3C250::AID-JMV12%3E3.0.CO;2-K	doi.org/10.1002/(SICI)1096-9071(199807)55:3<250::AID-JMV12>3.0.CO;2-K	Isolated strain	PRA			18/08/2025	OJCharles		OKA	A
2058	VZV	Clinical isolate	ORF36	Tdel26		65												Selection and Characterization of Varicella-Zoster Virus Variants Resistant to (R)-9-[4-Hydroxy-2-(Hydroxymethy)Butyl]Guanine	https://journals.asm.org/doi/10.1128/aac.45.6.1629-1636.2001?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed	doi.org/10.1128/aac.45.6.1629-1636.2001	Lab induced strain 	PRA			18/08/2025	OJCharles		VZV-32	A
2059	VZV	Clinical isolate	ORF36	E269del		20												Selection and Characterization of Varicella-Zoster Virus Variants Resistant to (R)-9-[4-Hydroxy-2-(Hydroxymethy)Butyl]Guanine	https://journals.asm.org/doi/10.1128/aac.45.6.1629-1636.2001?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed	doi.org/10.1128/aac.45.6.1629-1636.2001	Lab induced strain 	PRA			18/08/2025	OJCharles		VZV-32	A
2060	VZV	Clinical isolate	ORF36	N479I		80												Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet	https://link.springer.com/article/10.1007/s00430-011-0191-4	doi.org/10.1007/s00430-011-0191-4	Lab induced strain 	PRA			18/08/2025	OJCharles	would this method have found stop codons?	Clinical isolate	A
2061	VZV	Oka	ORF55	K350N		0.8										2500		Single Amino Acid Substitution Within the Helicase of Varicella Zoster Virus Makes It Resistant to Amenamevir	https://onlinelibrary.wiley.com/doi/10.1002/jmv.70080	doi.org/10.1002/jmv.70080	Recombinant BAC 	PRA			18/08/2025	OJCharles			A
